Morning-after pill may not work in heavier women

The European Medicines Agency says it has started a review of emergency contraceptives to see if they work less well in heavier women.

In November, French drug maker HRA Pharma announced its morning-after pill Norlevo was less effective in weighing more than 75 kilograms (165 pounds) and that it didn't work for women more than 80 kilograms (176 pounds). HRA Pharma changed its labels to warn patients after consulting with European regulators.

In a statement on Friday, the EMA said it would evaluate new data suggesting that a high body weight could compromise the effectiveness of the morning-after pill.

"This is an efficacy issue," said Monika Benstetter, an agency spokeswoman. "We need to find out what the association is with () and if there is a cut-off threshold for when the medicine becomes less effective."

HRA Pharma's Norlevo contains levonorgestrel, the same active ingredient in other medicines including ellaOne, Levonnelle and Levodonna. One of the studies that prompted the label change on Norlevo found the risk of emergency contraception failing was higher in women with a body mass index higher than 25, considered to be overweight.

EMA's Benstetter said the agency needed to perform an assessment of all products in the same category as Norlevo to ensure labels across the European Union are consistent. She said there was no timeline on when the review would be completed.

In November, the U.S. Food and Drug Administration said it was also studying the issue.

The morning-after pill can be taken up to 72 hours after unprotected sex. It contains a higher dose of the hormone in regular and works by preventing ovulation or fertilization of an egg. It has no effect if a woman is already pregnant.

Some doctors have previously advised that heavy women consider alternatives like a copper IUD, a birth control device that can be fitted on the uterus.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

New morning-after pill works for up to 5 days

Jan 29, 2010

(AP) -- A new type of morning-after pill is more effective than the most widely used drug at preventing pregnancies in women who had unprotected sex and also works longer, for up to five days, a new study says.

FDA panel to consider new 'morning-after pill'

Jun 08, 2010

A Food and Drug Administration advisory committee will meet June 17 to consider whether the agency should approve a new emergency contraceptive that studies show is more effective than Plan B, the only "morning-after pill" ...

Recommended for you

Most US babies get their vaccines, CDC says

17 hours ago

(HealthDay)—The vast majority of American babies are getting the vaccines they need to protect them from serious illnesses, federal health officials said Thursday.

Expression of privilege in vaccine refusal

Aug 27, 2014

Not all students returning to school this month will be up to date on their vaccinations. A new study conducted by Jennifer Reich, a researcher at the University of Colorado Denver, shows that the reasons why children may ...

User comments